CRDF icon

Cardiff Oncology
CRDF

Overview Fund Activity

22 hedge funds and large institutions have $1.12M invested in Cardiff Oncology in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$468K
2
EP
2
Elkhorn Partners
Nebraska
$56K
3
PFS
3
Prospera Financial Services
Texas
$15K
4
WS
4
Wedbush Securities
California
$20K
5
UBS Group
5
UBS Group
Switzerland
$12K

Top Sellers

1
TSS
1
Two Sigma Securities
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$414K
3
Morgan Stanley
3
Morgan Stanley
New York
$38K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
26
Princeton Capital Management
New Jersey
$0 141 – –
Bank of America
27
Bank of America
North Carolina
$0 332 +262 +374%
1
2